Work

Hypertrophic obstructive cardiomyopathy: review of surgical treatment

Year: 2017

Type: review

Abstract: Hypertrophic cardiomyopathy ranks among the most common congenital cardiac diseases, affecting up to 1 in 200 of the general population. When it causes left ventricular outflow tract obstruction, treatment is guided to reduce symptoms and the risk of sudden cardiac death. Pharmacologic therapy is the first-line treatment, but when it fails, surgical myectomy or percutaneous ablation of the hypertrophic myocardium are the standard therapies to eliminate subaortic obstruction. Both surgical myectomy and percutaneous ablation are proven safe and effective treatments; however, myectomy is the gold standard with a significantly lower complication rate and more complete and lasting reduction of left ventricular outflow tract obstruction.

Source: Asian Cardiovascular and Thoracic Annals

DOI: 10.1177/0218492317733111

Authors: Jonathan Price, Nicholas Clarke, Aslan Turer, Eduard Quintana, Carlos Mestres, Lynn Huffman, Matthias Peltz, Michael Wait, W Steves Ring, Michael Jessen, Pietro Bajona

Institutions: The University of Texas Southwestern Medical Center, Hospital Clínic de Barcelona, Universitat de Barcelona, University of Zurich, University Hospital Zurich, Scuola Superiore Sant'Anna

Language: English

Topic: Cardiomyopathy and Myosin Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2754687952

FWCI: 0.155

Cites: 82

Cited by: 10

Related to: 10